It is not enough to have the cleverest scientists, the best technology or the fairest prices. These days – perhaps more than ever before – culture may be the most important ingredient in pharmaceutical companies’ success. “Defining the kind of culture you want in the organization is absolutely fundamental,” said Emma Walmsley, CEO of GlaxoSmithKline PLC, at the FT Global Pharmaceutical and Biotechnology conference in London, November 2019. “Structural changes in R&D are not that significant. Spending time moving around the deckchairs … can be enormously disruptive.”
She did not explicitly mention the multiple R&D re-shuffles at GSK, which dragged on for about 15 years after the...
